"The Company estimates that Phase I/Phase II clinical trials for dCellVax would require approximately four years and expenses incurred in connection with Phase I/Phase II clinical trials for dCellVax would be approximately $5,500,000."
The opinions, comments, or concerns, expressed herein, are solely that of the screen name 'd5wr59mfi8'. They are not to be misconstrued as legal or financial advice and should not be followed. For financial advice, please see the guidance of financial p